Is Compound Glycyrrhizin Capsules a traditional Chinese medicine (TCM) patent drug?

　　Under normal circumstances, Compound Glycyrrhizin Capsules are not traditional Chinese medicine (TCM) preparations but rather Western medicine. The detailed analysis is as follows:

　　Traditional Chinese medicine (TCM) preparations refer to medicinal formulations made from processed traditional Chinese medicinal materials. These formulations typically have fixed prescription compositions and dosage forms, with clearly labeled functions, indications, methods of administration, dosages, and specifications. Compound Glycyrrhizin Capsules are a compound preparation whose main components include glycyrrhizin, glycine, methionine, etc. They are primarily used for treating chronic liver disease, improving abnormal liver function, and can also be used for treating eczema, dermatitis, alopecia areata, and other conditions. The components of Compound Glycyrrhizin Capsules are not traditional Chinese medicinal materials but rather chemical substances that have been extracted and processed. Therefore, based on the definition, Compound Glycyrrhizin Capsules do not meet the criteria for traditional Chinese medicine preparations.

　　Although Compound Glycyrrhizin Capsules contain components derived from traditional Chinese medicinal materials, they should be used according to Western medicine standards. Attention should be paid to drug interactions, and concurrent use with other drugs should be avoided to prevent possible adverse reactions.